Exploration of the activation mechanism of the epigenetic regulator MLL3: A QM/MM study

Sebastián Miranda-Rojas, Kevin Blanco-Esperguez, Iñaki Tuñón, Johannes Kästner, Fernando Mendizábal

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva


The mixed lineage leukemia 3 or MLL3 is the enzyme in charge of the writing of an epigenetic mark through the methylation of lysine 4 from the N-terminal domain of histone 3 and its deregulation has been related to several cancer lines. An interesting feature of this enzyme comes from its regulation mechanism, which involves its binding to an activating dimer before it can be catalytically functional. Once the trimer is formed, the reaction mechanism proceeds through the deprotonation of the lysine followed by the methyl-transfer reaction. Here we present a detailed exploration of the activation mechanism through a QM/MM approach focusing on both steps of the reaction, aiming to provide new insights into the deprotonation process and the role of the catalytic machinery in the methyl-transfer reaction. Our finding suggests that the source of the activation mechanism comes from conformational restriction mediated by the formation of a network of salt-bridges between MLL3 and one of the activating subunits, which restricts and stabilizes the positioning of several residues relevant for the catalysis. New insights into the deprotonation mechanism of lysine are provided, identifying a valine residue as crucial in the positioning of the water molecule in charge of the process. Finally, a tyrosine residue was found to assist the methyl transfer from SAM to the target lysine.

Idioma originalInglés
Número de artículo1051
EstadoPublicada - jul. 2021

Áreas temáticas de ASJC Scopus

  • Bioquímica
  • Biología molecular


Profundice en los temas de investigación de 'Exploration of the activation mechanism of the epigenetic regulator MLL3: A QM/MM study'. En conjunto forman una huella única.

Citar esto